Cancer clinical trials contribute critical information about the safety and efficacy of novel therapies but also provide patients access to cutting-edge treatments. Although trial enrollment has increased over the past 2 decades in the United States, notable differences remain between the sociodemographic profiles of patients affected by cancer and those participating in trials. Specifically, racial […]
Continue Reading >>